Pulse Biosciences (Nasdaq:PLSE) today announced the enrollment of the first patient in its NANOCLAMP AF study for treating ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

A pioneering procedure is showcasing the future of medicine. UC Health performed the region's first fully robotic heart procedure.

Dr. Greg Hundley: Yes, Peder, let's go. Dr. Peder Myhre: ...

Q3 2025 Earnings Call Transcript October 23, 2025 Roper Technologies, Inc. beats earnings expectations. Reported EPS is $5.14 ...

Almost half of Puerto Rico’s doctors have fled the island over the past decade, leading to a lack of specialists and ...

I read your recent column where you said that ivermectin has not been proven to be an effective treatment for cancer. I feel ...